Patents by Inventor Vermuri B. Reddy

Vermuri B. Reddy has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6100089
    Abstract: A rapid, sensitive, and quantitative method and assay system using transgenic animal cells and adult or embryonic transgenic animals to rapidly screen compounds for mutagenic or teratogenic activity. Each cell from a cell culture, a differentiated tissue from an animal or an animal embryo contains a target gene and a reporter gene, both including an animal promoter/enhancer, a coding sequence and a transcription termination signal, so that they are capable of expression in animal cells. The product of the target gene is capable of regulating expression of the reporter gene through interaction with a regulatory sequence in the reporter gene. In the preferred embodiment, the target gene lacI (lac repressor) is coupled to the reporter gene lacZ encoding beta-galactosidase, which is easily detectable by cytochemical or histochemical procedures.
    Type: Grant
    Filed: April 19, 1993
    Date of Patent: August 8, 2000
    Assignee: Exemplar Corporation
    Inventors: Vermuri B. Reddy, Cha-Mer Wei
  • Patent number: 5856137
    Abstract: Biologically active heterodimeric human fertility hormones composed of two different subunits, each subunit being synthesized in the same cell transformed by at least one cell expression vector having heterologous DNA encoding each subunit with each subunit being controlled by a separate promoter. Preferred human fertility hormones include hCG, hLH and hFSH.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: January 5, 1999
    Assignee: Genzyme Corporation
    Inventors: Vermuri B. Reddy, Nancy Hsiung, Anton K. Beck, Edward George Berstine
  • Patent number: 5767251
    Abstract: Biologically active heterodimeric human fertility hormones composed of two different subunits, each subunit being synthesized in the same cell transformed by at least one cell expression vector having heterologous DNA encoding each subunit with each subunit being controlled by a separate promoter. Preferred human fertility hormones include hCG, hLH and hFSH.
    Type: Grant
    Filed: January 22, 1993
    Date of Patent: June 16, 1998
    Assignee: Genzyme Corporation
    Inventors: Vermuri B. Reddy, Nancy Hsiung, Anton K. Beck, Edward George Bernstine
  • Patent number: 5639639
    Abstract: Biologically active heterodimeric human fertility hormones composed of two different subunits, each subunit being synthesized in the same cell transformed by at least one cell expression vector having heterologous DNA encoding each subunit with each subunit being controlled by a separate promoter. Preferred human fertility hormones include hCG, hLH and hFSH.
    Type: Grant
    Filed: June 30, 1994
    Date of Patent: June 17, 1997
    Assignee: Genzyme Corporation
    Inventors: Vermuri B. Reddy, Nancy Hsiung, Anton K. Beck, Edward George Bemstine
  • Patent number: 5639640
    Abstract: The correct sequence is disclosed for the beta subunit of human follicle stimulating hormone which, when present in a recombinant heterodimeric human fertility hormone allows the production of biologically active hormone. DNA coding for such beta subunit of human FSH may thus be prepared as well as expression vectors containing such DNA and cells transfected therewith.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: June 17, 1997
    Assignee: Genzyme Corporation
    Inventors: Vermuri B. Reddy, Nancy Hsiung, Anton K. Beck, Edward George Bernstine
  • Patent number: 5604131
    Abstract: A nucleic acid construct is described which when expressed in cells, results in the production of APP695, APP751 and APP770. The construct is the cDNA for APP770 with the genomic sequences encoding the KI and OX-2 regions substituting for those regions present in the cDNA.
    Type: Grant
    Filed: September 17, 1993
    Date of Patent: February 18, 1997
    Assignee: Athena Neurosciences, Inc.
    Inventors: Samuel Wadsworth, Benjamin Snyder, Vermuri B. Reddy, Chamer Wei
  • Patent number: 5344773
    Abstract: A replicable expression vector capable, in a transformed host mammallian cell, of expressing a DNA sequence encoding active human TPA which, when expressed in the host cell, yields active TPA which lacks one or more of the TPA-bound N-linked carbohydrate moieties of naturally occurring human TPA.
    Type: Grant
    Filed: October 1, 1985
    Date of Patent: September 6, 1994
    Assignee: Genzyme Corporation
    Inventors: Cha-Mer Wei, Nancy Hsiung, Vermuri B. Reddy, Jeffrey F. Lemontt, William Dackowski, Richard Douglas, Edward S. Cole, Richard D. Purcell, Jr., David Tai-Yui Lau
  • Patent number: 4840896
    Abstract: Biologically active heteropolymeric protein composed of a plurality of subunits, each subunit being synthesized by a cell having an expression vector heterologous DNA encoding the subunit.
    Type: Grant
    Filed: November 2, 1983
    Date of Patent: June 20, 1989
    Assignee: Integrated Genetics, Inc.
    Inventors: Vermuri B. Reddy, Nancy Hsiung, Anton K. Beck, Edward G. Bernstine